Akreos MICS lens gets the thumbs up

Article

Cataract surgery with the Akreos MI60 microincision lens (Bausch & Lomb) is a safe and effective procedure.

Cataract surgery with the Akreos MI60 microincision lens (Bausch & Lomb) is a safe and effective procedure, according to Jorge Alio and co-workers from VISSUM Instituto Oftalmologica de Alicante, Spain and study groups in France, Germany, Italy and Sweden.

The study enrolled 98 eyes to be implanted with the Akreos lens using bimanual phaco with the Millenium system (Bausch & Lomb), a wound-assisted MI60 lens implantation and a 1.8 mm cartridge. Mean age of subjects was 70 years and the mean preoperative spherical equivalent was -0.53±2.93 D.

The corneal incision changed from a pre-implant value of 1.68±0.24 mm to a post-implant value of 1.82±0.16 mm, implying a wound stretch with implantation of 0.14±0.22 mm. Postoperative spherical equivalent was -0.05±0.90 D, while best corrected visual acuity (BCVA) improved from 0.42±0.25 to 0.04±0.18.

The research group believe that cataract surgery using the Akreos MI60 microincision lens produces excellent visual and refractive outcomes.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.